- Home
- IOVA vs NRDS Comparison
IOVA vs NRDS Comparison
Compare IOVA & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- NRDS
- Stock Information
- Founded
- IOVA 2007
- NRDS 2009
- Country
- IOVA United States
- NRDS United States
- Employees
- IOVA N/A
- NRDS N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- NRDS EDP Services
- Sector
- IOVA Health Care
- NRDS Technology
- Exchange
- IOVA Nasdaq
- NRDS Nasdaq
- Market Cap
- IOVA 975.1M
- NRDS 785.4M
- IPO Year
- IOVA N/A
- NRDS 2021
- Fundamental
- Price
- IOVA $2.17
- NRDS $10.47
- Analyst Decision
- IOVA Buy
- NRDS Buy
- Analyst Count
- IOVA 11
- NRDS 5
- Target Price
- IOVA $11.90
- NRDS $13.80
- AVG Volume (30 Days)
- IOVA 9.8M
- NRDS 505.2K
- Earning Date
- IOVA 11-06-2025
- NRDS 10-28-2025
- Dividend Yield
- IOVA N/A
- NRDS N/A
- EPS Growth
- IOVA N/A
- NRDS N/A
- EPS
- IOVA N/A
- NRDS 0.60
- Revenue
- IOVA $241,525,000.00
- NRDS $771,200,000.00
- Revenue This Year
- IOVA $68.14
- NRDS $16.45
- Revenue Next Year
- IOVA $56.64
- NRDS $7.85
- P/E Ratio
- IOVA N/A
- NRDS $18.41
- Revenue Growth
- IOVA 636.99
- NRDS 28.75
- 52 Week Low
- IOVA $1.64
- NRDS $7.55
- 52 Week High
- IOVA $12.51
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- IOVA 46.63
- NRDS 43.43
- Support Level
- IOVA $1.97
- NRDS $10.67
- Resistance Level
- IOVA $2.38
- NRDS $11.33
- Average True Range (ATR)
- IOVA 0.13
- NRDS 0.35
- MACD
- IOVA 0.02
- NRDS -0.04
- Stochastic Oscillator
- IOVA 48.78
- NRDS 4.27
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.